Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma lipids and stroke.

P B Gorelick1, T Mazzone

  • 1Department of Neurological Sciences, Center for Stroke Research, Rush Medical College and Rush Medical Center, Chicago, Illinois, USA.

Journal of Cardiovascular Risk
|September 29, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of a Diverse Cohort of Stroke Patients with SARS-CoV-2 and Outcome by Sex.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2020
Same author

Acute ischemic stroke and transient ischemic attack: A costly business and a strategy to reduce costs (the "Time-Zero" plan).

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

The effects of cerebral white matter changes on cardiovascular responses to cognitive and physical activity in a stroke population.

Psychophysiology·2012
Same author

Is asymptomatic hemorrhagic transformation really innocuous?

Neurology·2012
Same author

Thalamic integrity underlies executive dysfunction in traumatic brain injury.

Neurology·2010
Same author

Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia.

Diabetes, obesity & metabolism·2009

High lipid levels are a known risk factor for heart disease, but their role in stroke causation is debated. Further research, including clinical trials on lipid-lowering for stroke prevention, is needed to clarify this connection.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Public Health

Background:

  • High plasma lipid levels are a significant modifiable risk factor for coronary heart disease.
  • The role of plasma lipids as a risk factor for stroke remains controversial and not well-established.
  • Existing evidence links lipids to systemic arterial disease and suggests a potential role in stroke development.

Purpose of the Study:

  • To discuss the ongoing controversy regarding plasma lipids as a risk factor for stroke.
  • To highlight the need for further investigation into the relationship between lipids and stroke.
  • To propose a clinical trial for primary stroke prevention through lipid lowering.

Main Methods:

  • Review of pathophysiologic evidence linking lipids to systemic artery disease.

Related Experiment Videos

  • Analysis of results from clinical trials on coronary heart disease prevention and lipid-lowering.
  • Discussion of the current scientific debate on plasma lipids and stroke risk.

    • Main Results:

    • Pathophysiologic data and coronary heart disease trial outcomes suggest lipids may contribute to stroke causation.
    • Despite this, lipids are not yet established as a definitive risk factor for stroke.
    • A clear understanding of lipids' role in stroke remains elusive.

    Conclusions:

    • Clinical trials targeting lipid-lowering for primary stroke prevention are warranted.
    • Such trials would help resolve the plasma lipid-stroke controversy.
    • This research is crucial for advancing stroke prevention strategies in the 21st century.